Our mission is to help you obtain financial freedom. Checkout Our Youtube Channel Checkout Our Youtube Channel
Blog

From Struggles To Strategy: The Companies Making Big Moves with Reverse Stock Splits

This week has seen a flurry of strategic maneuvers in the stock market as several prominent companies have executed reverse stock splits, drawing significant attention from financial observers. These moves, while sounding complex, are crucial tactics used by companies to stabilize their stock prices and maintain their listings on major exchanges.

Let’s break down what a reverse stock split actually entails. Let’s you own 10 shares of a company, each valued at $100. After a 1-for-10 reverse stock split, you would now hold just 1 share worth $1,000. The total value of your investment remains the same, but the number of shares you own decreases. Companies typically perform reverse stock splits to raise their share prices, particularly when they are close to falling below the minimum price required by exchanges like Nasdaq or the NYSE. The minimum price is set as a requirement to ensure liquidity and stability, and if a company’s share price stays too low for too long. Thus, a reverse stock split can be a strategic move to maintain continued access to capital markets and retain investor interest.

One of the first companies to implement a reverse stock split this week was Gingko Bioworks Holdings (DNA), which executed a 1-for-40 split. In this process, forty shares were consolidated into one. Similarly, Surf Air Mobility (SRFM), a company specializing in electric aviation, and SITE Centers (SITC), a real estate investment trust managing open-air shopping centers, also executed reverse stock splits, 1-for-7 and 1-for-4 reverse splits, respectively. All of these companies have not performed so well in the past year, and implemented such reverse stock splits to retain their NYSE listing and stabilize their market presence.

In addition, for companies listed on Nasdaq, Cadrenal Therapeutics (CVKD), ENDRA Life Sciences (NDRA), and Aligos Therapeutics (ALGS) executed reverse stock splits to meet the exchange’s listing requirements. Cadrenal Therapeutics completed a 1-for-15 reverse split, ENDRA Life Sciences performed a 1-for-50 split, and Aligos Therapeutics carried out a 1-for-25 reverse split. Meanwhile, Faraday Future Intelligent Electric (FFIE) and Better Home Finance Holding Company (BETR) also implemented 1-for-40 and 1-for-50 reverse splits, respectively, to maintain their Nasdaq listings and address market challenges.

Now, why should you care? Well, as investors, these stock splits might feel like a double-edged sword. On one side, they can signal that a company is facing some tough financial challenges or market difficulties, which might raise concerns about its stability. But here’s the flip side: reverse stock splits can also be a savvy move to boost the stock price, which often means that the company is actively working to turn things around and improve its market position. So, while a reverse split might initially seem troubling, it can also be a sign that the company is making a serious effort to strengthen its future prospects.

As for how these reverse stock splits will affect the companies, we’ll have to wait and see. The real impact on their stock prices and overall market performance will become clearer in the next few weeks as the market adjusts and investors react.

0 Comments
Inline Feedbacks
View all comments

More ClearValue Insights

Default Thumbnail

QQQ Likely to Test the Yellow Trendline

QQQ has essentially moved sideways since Sept. 6, and is likely to start trending up to the yellow trendline. The yellow line is sloped downward and decreases over time so the longer it takes the lower the price target will be. For now $466.30 is a realistic target for QQQ to reach over the next […]

Read More
Default Thumbnail

Slow Progress to the Upside for NVDA

NVDA has been gradually rising over time, and is now trading near $109. I think NVDA will influence the direction of the stock market. For now there is volatility with wicks in both direction, and the price action is still neutral but slightly bullish. The narrative is that the stock market is having a negative […]

Read More
Default Thumbnail

VIX Trading Near Resistance

The VIX is trending up today with 9%+ gains, but is still trading near a key $21.81 resistance line. I would monitor for a break or rejection at $21.81. I think the Presidential election brings a lot of uncertainty in the markets, which leads to volatility and a rise in the VIX. If the VIX […]

Read More